Our mission is opening a digital front door to a new kind of healthcare system, one that provides greater access to high quality, convenient and affordable care. No matter who a person is, where they come from, what they look like, or if they have insurance or not—Hims & Hers connects consumers with licensed medical professionals and enables everyone to seek health and wellness care.

HIMS

Andrew Dudum

Chief Executive Officer

Melissa Baird

Chief Operating Officer

Soleil Boughton

Chief Legal Officer and Corporate Secretary

Yemi Okupe

Chief Financial Officer

Chief Executive Officer And Board Of Director

Alex Bard

Board Of Director

Dr. Toby Cosgrove

M.D. Board Of Director

Kirsten Green

Jules Maltz

David Wells

Lynne Chou O’keefe

Andrea Perez

Ambar Bhattacharyya

Dr. Patrick Carroll

About HIMS

Ultime notizie per Hims & Hers Health (NYSE:HIMS) Azioni

Hims & Hers Health

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Equities

News

Health Care

Markets

Hims & Hers Health, Inc. Class A Common Stock

Novo Nordisk annuncia risultati positivi per il farmaco contro l&#39;obesità infantile; richiesta di approvazione a FDA ed EMA.

Novo Nordisk: il farmaco per l&#39;obesità infantile mostra buoni risultati

Hims & Hers Health Inc

Cathie Wood, CEO of ARK Invest, has shared her insights on the potential impact of a Trump administration on Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and decentralized finance (DeFi). Wood believes that the administration could bring much-needed &#8220;regulatory clarity&#8221; to the fintech sector, particularly if&nbsp;Gary Gensler&nbsp;steps down from his position.
What Happened: During a&nbsp;webinar prerecorded on Nov. 15 and published on Friday, Wood discussed how the Trump administration might influence the digital asset revolution, led by Bitcoin. 
&#8220;If Gary Gensler leaves, that is going to open us up to regulatory clarity and probably, given the Trump administration&#8217;s pronouncements over the last few month, give much more focus on digital asset revolution, broadly led by Bitcoin, which they may put in the Treasury&#8217;s strategic reserve,&#8221; she said.
Wood suggested the possibility of adding Bitcoin to the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42121376/strategic-bitcoin-reserve-wouldnt-require-new-taxpayer-dollars-says-sen-cynthia-lummis">U.S. Treasury&#8217;s strategic reserve</a>, given the current circulation of over 19 million Bitcoin and a cap of 21 million. According to Wood, the government might aim to acquire 1 million Bitcoins over time.
Regarding DeFi, Wood highlighted the potential for peer-to-peer lending to remove intermediaries in financial transactions.&nbsp;Yassin Elmandjra, ARK&#8217;s director of digital assets, noted the accelerating&nbsp;trend of using cryptocurrency for&nbsp;commerce, driven by technological and regulatory advancements.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42097462/dogecoin-millionaire-shares-50-million-meme-coin-strategy-for-2025-pepe-brett-are-this-bull-runs-doge-shiba-inu?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8216;Dogecoin Millionaire&#8217; Shares $50 Million Meme Coin Strategy For 2025: Pepe, Brett Are This Bull Run&#8217;s DOGE, Shiba Inu</a>
Elmandjra stressed the importance of governments establishing clear regulations on compliance, tax implications, and consumer protection to enable businesses to navigate the evolving landscape effectively.
Why It Matters: Wood&#8217;s predictions come amidst her ambitious price targets for Bitcoin, including a bull case of $3.8 million if more companies incorporate the cryptocurrency into their balance sheets. However, a recent&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42122886/cathie-woods-3-8-million-bitcoin-vision-met-with-doubt-83-say-not-by-2030">Benzinga survey&nbsp;revealed</a> skepticism, with 83% of respondents doubting this target will be met by 2030.
Additionally, ARK Invest has identified an &#8220;uptrend&#8221; in <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41352094/cathie-woods-ark-invest-says-uptrend-developing-in-bitcoins-market-structure-because-of-th">Bitcoin&#8217;s market structure</a>, attributed to oversold conditions in the Stablecoin Supply Ratio Oscillator (SSRO). This indicator, which measures Bitcoin&#8217;s potential purchasing power, hit a significant low in September, a level not seen since the 2022 bear market. The SSRO is calculated by dividing Bitcoin&#8217;s supply by the supply of major stablecoins, providing insights into Bitcoin&#8217;s market dynamics.
Price Action: As per <a href="https://pro.benzinga.com">Benzinga Pro,</a> at 8:03 am ET, Bitcoin was trading at $98,764.01, Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) at $3,345.98 and Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) was at $0.4045. In the past 14 days, post the elections, Bitcoin&#8217;s value experienced 29.9% increase, Ethereum increased by 14.7% and Dogecoin saw a 105.5% hike. 
Meanwhile, ARK 21Shares Bitcoin ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKB#BATS">ARKB</a>), which provides exposure to bitcoin which is kept in cold storage was trading only slightly higher at 0.58% during pre-market hours.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42052184/will-shiba-inu-coin-reach-1-cent-by-2025-47-of-benzinga-readers-say?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Will Shiba Inu Coin Reach 1 Cent By 2025? 47% Of Benzinga Readers Say…</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image courtesy: ArkInvest

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

General

$BTC

$DOGE

$ETH

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

Ark Invest's Cathie Wood Says Team Trump Would Give 'Regulatory Clarity' For Bitcoin And Other Digital Assets: '...Which They May Put In The Treasury's Strategic Reserve'

WIIM

BENF

BEneficient shares are trading higher after the company announced its stockholder equity figure now likely meets Nasdaq's minimum requirement and will regain compliance status.

EHang Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EH#NASDAQ">EH</a>) saw its shares rise in premarket trading on Friday following the announcement of a new share repurchase program.
The company&#8217;s Board of Directors has approved the repurchase of up to $30 million worth of American Depositary Shares (ADSs) or ordinary shares over the next 12 months.
Huazhi Hu, Founder, Chairman, and CEO of EHang, highlighted that the repurchase program reflects the company&#8217;s belief in its future potential and its commitment to delivering value to shareholders.
He emphasized EHang&#8217;s focus on advancing its leadership in providing safe, pilotless, and sustainable electric Vertical Take-Off and Landing (eVTOL) solutions within the rapidly growing Urban Air Mobility (UAM) sector.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42133364/us-stocks-on-edge-but-likely-to-end-the-week-in-the-green-trumps-treasury-pick-in-focus-expert-says-case-for-fed-pause-in-december-getting-stronger" rel="noreferrer noopener">US Stocks Set To Open Lower On Friday As Investors Eye Cyclical Stocks: Trump&#8217;s Treasury Pick In Focus, Expert Says Case For Fed Pause In December&#8217; Getting Stronger&#8217;</a>
&#8220;Looking ahead, we remain focused on advancing our leadership in providing safe, pilotless, and sustainable eVTOL solutions in the Urban Air Mobility sector, while maintaining a disciplined approach to capital allocation to ensure sustainable growth and profitability,&#8221; Hu said.
In a related development, EHang recently unveiled a new UAM Hub at <a target="_blank" href="https://www.benzinga.com/news/small-cap/24/11/41948048/ehang-expands-evtol-infrastructure-new-uam-hub-powers-up-future-of-autonomous-flights" rel="noreferrer noopener">Luogang Central Park in Hefei, Anhui Province, China</a>.
This marks the second vertiport in the region, following the opening of the UAM Operations Center earlier this year. The Hub is designed to support the operation of EHang&#8217;s EH216-S pilotless passenger drones, which play a central role in the company&#8217;s expanding efforts in the eVTOL market. The new facility, named &#8220;Ascend,&#8221; features a distinctive upward spiral design, symbolizing the growth of the low-altitude economy in the region.
This infrastructure milestone strengthens EHang&#8217;s partnership with Hefei City, helping to advance the commercial use of eVTOL aircraft in Eastern China.
Price Action: EH shares are trading higher by 1.96% to $13.55 premarket at last check Friday.
Image: Shutterstock/ bangoland
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42130693/bitcoins-path-to-100k-inevitable-but-leverage-to-the-gills-warns-mike-novogratz-predicts-80k-correction-ahead" target="_blank" rel="noreferrer noopener">Bitcoin&#8217;s Path To $100K &#8216;Inevitable&#8217; But Crypto Community Is &#8216;Leveraged To The Gills,&#8217; Warns Galaxy&#8217;s Mike Novogratz, Predicts Correction To $80K Ahead</a></li>
</ul>

Buybacks

Movers

What's Going On With EHang Stock Today?

Morgan Stanley analyst Alex Straton maintains Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) with a Overweight and raises the price target from $29 to $30.

Price Target

Analyst Ratings

Morgan Stanley Maintains Overweight on Gap, Raises Price Target to $30

A safe, secure, and private way to pay with iPhone and Apple Watch using girocard More customers to benefit from payments with nationwide usability Commerzbank AG announces that customers can use their giro card with Apple Pay - a safe and secure way to pay that helps customers choose contactless payment options with their iPhone or Apple Watch while using the power of the iPhone to protect every transaction.
<a href="https://www.commerzbank.de/group/newsroom/press-releases/applepay-girocard.html" title="https://www.commerzbank.de/group/newsroom/press-releases/applepay-girocard.html">https://www.commerzbank.de/group/newsroom/press-releases/applepay-girocard.html</a>

AAPL

CRZBF

'Commerzbank introduces Apple Pay to its girocard customers' - Commerzbank

Wells Fargo analyst Gary Mobley initiates coverage on Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Equal-Weight rating and announces Price Target of $570.

Initiation

SNPS

Wells Fargo Initiates Coverage On Synopsys with Equal-Weight Rating, Announces Price Target of $570

Morgan Stanley analyst Natasha Bonnet initiates coverage on Ermenegildo Zegna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZGN#NYSE">ZGN</a>) with a Underweight rating and announces Price Target of $7.2.

Morgan Stanley Initiates Coverage On Ermenegildo Zegna with Underweight Rating, Announces Price Target of $7.2

ESTC

Elastic shares are trading higher after the company reported better-than-expected Q2 financial results and issued FY25 guidance above estimates.

Pyxis Tankers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXS#NASDAQ">PXS</a>) reported quarterly earnings of $0.31 per share. This is a 19.23 percent increase over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $13.792 million which missed the analyst consensus estimate of $15.150 million by 8.96 percent. This is a 24.27 percent increase over sales of $11.098 million the same period last year.

Earnings

Earnings Misses

Pyxis Tankers Q3 2024 GAAP EPS $0.31 Up From $0.26 YoY, Sales $13.792M Miss $15.150M Estimate

Tapestry shares are trading higher after the company announced agreements for a $2 billion Accelerated Share Repurchase program.

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">43.94</td>
<td align="right">0.18</td>
<td align="right">0.41</td>
<td>2.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">82.21</td>
<td align="right">0.32</td>
<td align="right">0.39</td>
<td>14.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">144.40</td>
<td align="right">0.37</td>
<td align="right">0.25</td>
<td>1.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">215.27</td>
<td align="right">0.27</td>
<td align="right">0.12</td>
<td>183</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">50.22</td>
<td align="right">0.05</td>
<td align="right">0.09</td>
<td>234.5K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">97.00</td>
<td align="right">-0.12</td>
<td align="right">-0.13</td>
<td>9.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.06</td>
<td align="right">-0.03</td>
<td align="right">-0.04</td>
<td>858</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">233.43</td>
<td align="right">-0.05</td>
<td align="right">-0.03</td>
<td>21.7K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For November 22, 2024

Targeting $200B Digital Grocery Market With Key Retailers Like Fareway Stores And Vroom Delivery

PUBM

PubMatic Partners With DIGITS Agency To Monetize Digital Grocery Advertising Through Scalable AdTech Platform

Wells Fargo analyst Gary Mobley initiates coverage on Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) with a Overweight rating and announces Price Target of $23.

ALGM

Wells Fargo Initiates Coverage On Allegro Microsystems with Overweight Rating, Announces Price Target of $23

Leerink Partners analyst Jeffrey La Rosa initiates coverage on Janux Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JANX#NASDAQ">JANX</a>) with a Outperform rating and announces Price Target of $79.

JANX

Leerink Partners Initiates Coverage On Janux Therapeutics with Outperform Rating, Announces Price Target of $79

Keybanc analyst Tim Rezvan maintains Gulfport Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPOR#NYSE">GPOR</a>) with a Overweight and raises the price target from $165 to $205.

GPOR

Keybanc Maintains Overweight on Gulfport Energy, Raises Price Target to $205

APTO

Aptose Biosciences shares are trading lower after the company announced the pricing of an $8 million public offering.

Offerings

Aptose Biosciences Prices $8M Public Offering Of 40M Shares And 20M Warrants At $0.20 Per Unit; Warrants Priced At $0.25 Per Share And Expire In Five Years, With Closing Expected On November 25, 2024

Goldman Sachs analyst Adam Bubes initiates coverage on AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) with a Buy rating and announces Price Target of $130.

Goldman Sachs Initiates Coverage On AECOM with Buy Rating, Announces Price Target of $130

Wells Fargo analyst Joe Quatrochi initiates coverage on ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Overweight rating and announces Price Target of $155.

Wells Fargo Initiates Coverage On ARM Holdings with Overweight Rating, Announces Price Target of $155

SBFM

Sunshine Biopharma shares are trading higher after its Nora Pharma subsidiary launched Ursodiol, a generic version of URSO DS.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS – Research Report) and Ce...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Celcuity (CELC)

TD Cowen analyst Jonna Kim maintained a Buy rating on Hims & Hers Health (HIMS – Research Report) today and set a price target of $28.00. The compa...

TD Cowen Sticks to Its Buy Rating for Hims & Hers Health (HIMS)

Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead

Hims & Hers Health (HIMS) announced that Hims & Hers customers will now be able to supplement their treatment plan with daily meal replacement bars...

Hims & Hers announces daily meal replacement bars and shakes

A joint status report that was filed in the U.S. District Court for the Northern District of Texas states in part: "To assist FDA in its reevaluati...

Hims & Hers jumps as status report says patients unable to obtain branded GLP-1s

Hims & Hers closes up 10% as Lilly tirzepatide compounding dispute resolution delayed

In a report released today, Daniel Grosslight from Citi maintained a Hold rating on Hims & Hers Health (HIMS – Research Report), with a price targe...

Hold Rating on Hims & Hers Health Amidst Regulatory Uncertainty and Market Risks

Citi notes that the FDA said in a status report filed in a Texas court that it needs more time to determine if Eli Lilly's (LLY) tirzepatide should...

FDA tirzepatide status report 'moderately positive' for Hims & Hers, says Citi

Hims & Hers Health ( ($HIMS) ) has provided an update. Hims & Hers Health, Inc. has expanded its board of directors, appointing Deb Autor as the te...

Hims & Hers Health Expands Board with New Appointment

Truist Financial analyst Jailendra Singh maintained a Hold rating on Hims & Hers Health (HIMS – Research Report) today. The company's shares closed...

Truist Financial Sticks to Their Hold Rating for Hims & Hers Health (HIMS)

ADRNY

AHODF

AMZN

CELC

COST

LFMD

Screenshot 2024-09-04 at 5.36.44 PM

Biotech

MGRX

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform

Screenshot 2024-07-09 at 1.59.17 PM

Erectile Function Vs Erectile Dysfunction: How MangoRx&#39;s (NASDAQ: MGRX) Product Sets Itself Apart And Caters To A Large Market (Pun Intended)

Press Releases

Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders

Hims & Hers Health Set to Join S&P SmallCap 600

Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024

Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers

Define Ventures Appoints Bruce Broussard as Venture Partner

How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals

Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results

Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue

Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions

Hims & Hers Expands Nutrition Support to Fuel Customers' Weight Loss Journeys

SPGI

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Amedisys

AMN Healthcare Services

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Comments

Hims & Hers Health

Notizie

Ultime notizie per Hims & Hers Health (NYSE:HIMS) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO